Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Cost of Goods Sold: -$2,878M in Q3 2026, up 1.1% from a year earlier.
Latest, Q3 2026
-2,878
Period ended Sep 30, 2026
Change on a year earlier
+1.1%
-2,847 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
32
Documents cited below
Where the Q3 2026 figure comes from
“|| Cost of goods sold | – 3 608 | 695 | 35 | – 2 878 | – 2 847”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Core Cost of Goods Sold ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-cogs
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.